JeffreyGLefleinMD

PubMed

• 2 citations
  Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
  Marcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, Gordon Sussman, Michihiro Hide, Sarbjit Saini, Clive Grattan, Daria Fomina, Dimitrios Rigopoulos, Frederic ...> ;Lancet. 2024 Jan 13
• 23 citations
  The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children.
  William E. Berger, Jeffrey Leflein, David E Geller, Bhash Parasuraman, Christopher J. Miller, C.D. O'Brien, L. O'Dowd> ;Allergy and Asthma Proceedings. 2010 Jan 1
• 9 citations
  Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethaso...
  Michael Noonan, Jeffrey Leflein, Jonathan Corren, Heribert Staudinger> ;BMC Pediatrics. 2009 Jul 13
• 21 citations
  Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multic...
  Eli O. Meltzer, Jon E. Stahlman, Jeffrey Leflein, Steven M. Meltzer, Junghee Lim, Anand A. Dalal, Barbara A. Prillaman, Edward E. Philpot> ;Clinical Therapeutics. 2008 Feb 1
• 4 citations
  Safety features of budesonide inhalation suspension in the long-term treatment of asthma in young children.
  Jeffrey Leflein, James W. Baker, Howard Eigen, Ewa Lyzell, L. McDermott> ;Advances in Therapy. 2005 May 1
• 56 citations
  Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
  Anders Åkerlund, Morgan Andersson, Jeffrey Leflein, Torben Lildholdt, Niels Mygind> ;The Journal of Allergy and Clinical Immunology. 2005 Mar 1
• 57 citations
  Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
  Jeffrey G. Leflein, Stanley J. Szefler, Kevin R. Murphy, Sherahe Fitzpatrick, Mario Cruz-Rivera, Christopher J. Miller, Joseph A. Smith> ;Pediatrics. 2002 May 1
• 13 citations
  Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma.
  J G Leflein, S M Gawchik, S P Galant, E Lyzell, M Young, M Cruz-Rivera, K Walton-Bowen, J A Smith, S Fitzpatrick> ;Allergy and Asthma Proceedings. 2001 Nov 1
• 52 citations
  Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persist...
  , , , , , , , , , , , , , , , , , , , , , , > ;The Journal of Allergy and Clinical Immunology. 2000 Nov 1
• 41 citations
  Comparable Efficacy of Administration with Face Mask or Mouthpiece of Nebulized Budesonide Inhalation Suspension for Infants and Young Children with Persistent Asthma
  Michael Mellon, Jeffrey Leflein, Karen Walton-Bowen, Mario Cruz-Rivera, Sherahe Fitzpatrick, Joseph A. Smith> ;American Journal of Respiratory and Critical Care Medicine. 2000 Aug 1
• 9 citations
  Delivery of glucocorticoids by jet nebulization: Aerosol characteristics and output☆☆☆★★★
  Jeffrey G. Leflein, Eleanor E. Brown, Malcolm R. Hill, Kelly Hw, Loffert Dt, Harold S. Nelson, Stanley J. Szefler> ;The Journal of Allergy and Clinical Immunology. 1995 May 1
• Join now to see all